Stockscreener 앱 받기
73.52
6.06%
4.20
시간 외 거래:
74.60
1.08
+1.47%
Cg Oncology Inc 주식(CGON)의 최신 뉴스
CG Oncology bladder cancer trial results published in Lancet - Investing.com
CG Oncology Announces Lancet Oncology Publication of Phase 3 BOND-003 Cohort C Results for Cretostimogene in High-Risk BCG-Unresponsive Bladder Cancer - Quiver Quantitative
CG Oncology Announces Publication of Pivotal Phase 3 BOND-003 Cohort C Study Results in The Lancet Oncology - GlobeNewswire Inc.
BlackRock, Inc. (CGON) discloses 6.8% beneficial ownership in CG Oncology - Stock Titan
CGON (CGON) filer discloses 50,000-share sale plan and recent stock sales - Stock Titan
CG Oncology Market Sentiment - Benzinga España
CG Oncology Inc (CGON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CG Oncology, Inc. Revenue Breakdown – NASDAQ:CGON - TradingView
CGON|CG Oncology Inc|Price:69.795|Chg%:+0.475 - TradingKey
CG Oncology Inc (CGON) Institutional Confidence - TradingKey
CG Oncology Inc (CGON) Cash Flow - TradingKey
TradingKey - TradingKey
CG Oncology Inc (CGON) Income Statement - TradingKey
CG Oncology Inc (CGON) Valuation: PE, PB & Fair Value Analysis - TradingKey
CG Oncology Inc (CGON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CG Oncology Inc (CGON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CG Oncology Inc (CGON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Midday Stock Roundup: Shares of loanDepot up 7% - Orange County Business Journal
CG Oncology Inc (CGON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Intratumoral Cancer Therapies Market to Reach USD 3.15 Billion - openPR.com
CG Oncology (CGON) Rises 2.6% as Biotech Sentiment Lifts Oncology-Focused NamesThematic ETF Flow - dars.gov.et
CGON (CGON) insider files to sell 50,000 shares after option exercise - Stock Titan
CG Oncology appoints David Fela as vice president to strengthen quality control focus - Traders Union
Biotech Darling CG Oncology Suddenly Falls Out Of Favor - TipRanks
CG Oncology: Priced To Perfection On Future Pipeline Success - Seeking Alpha
CG Oncology director Leonard Post disposes of 1,000 shares for $71,170 - Bitget
CG Oncology (CGON) Surges 3.4% as Bullish Momentum Builds Above Key SupportRounding Bottom - dars.gov.et
CG Oncology (CGON) director sells 1,000 shares at $71.17 - Stock Titan
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter - Sahm
Ani Pharmaceuticals Announces Intent To Appeal Rulings In CG Oncology Matter - TradingView
ANI Pharmaceuticals to Appeal Delaware Ruling Denying Post-Trial Motions in CG Oncology Asset Dispute - Quiver Quantitative
Form 144 CG ONCOLOGY For: 15 July By Investing.com - Investing.com Nigeria
CG Oncology, Inc. SEC Filing (Jul 15, 2026) - Stock Titan
CG Oncology: Advancing Toward a Potential Breakthrough in Bladder Cancer Treatment - Kalkine
CG Oncology (CGON) director exercises options, sells 24,165 shares - Stock Titan
CG Oncology (CGON) Declines Moderately as Biotech Sector Faces HeadwindsMomentum ETF - dars.gov.et
CG Oncology Stock Stumbles After Hitting Fresh Peak - TipRanks
CG Oncology Stock Gains 12% in Three Months: What's Driving It? - Yahoo Finance
Form DEF 14A CG Oncology Inc For: 10 July By Investing.com - Investing.com Australia
Form 144 CG Oncology For: 10 July By Investing.com - Investing.com South Africa
Cognition Therapeutics (NASDAQ: CGON) insider plans sale of 20,237 shares - Stock Titan
Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating - Moomoo
CG Oncology (CGON) Investor presentation Summary - Quartr
CG Oncology (CGON) Jefferies Global Healthcare Conference 2026 Summary - Quartr
CG Oncology (CGON) Bank of America Global Healthcare Conference 2026 Summary - Quartr
A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $77 to $108 - Moomoo
CGONCg Oncology Inc Options - Finviz
CGON,QURE Volatility & Greeks - Finviz
CG Oncology Stock (CGON) Opinions on Director's Massive Share Purchase - Quiver Quantitative
CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director POST LEONARD E - Moomoo
Form 144 CG ONCOLOGY INC For: 1 July By Investing.com - Investing.com UK
Insider sale notice: CGON (NASDAQ: CGON) 3,928 shares via exercise - Stock Titan
Hedge Fund and Insider Trading News: Paul Singer, Warren Buffett, Ray Dalio, George Soros, Millennium Management, Point72 Asset Management, Citadel Investment Group, CG Oncology Inc (CGON), Beam Therapeutics Inc (BEAM), and More - Insider Monkey
CG Oncology stock hits all-time high at 75.79 USD - Investing.com
1.97%
0.83%
자본화:
|
볼륨(24시간):